The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Prostate Cancer Biomarker Market Research Report 2025
Synopsis
Prostate cancer is the development of cancer in the prostate, a gland in the male reproductive system.
The global Prostate Cancer Biomarker market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The prostate cancer biomarker market is expected to witness a fast growth owing to rising prevalence of prostate cancer.
This report aims to provide a comprehensive presentation of the global market for Prostate Cancer Biomarker, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Prostate Cancer Biomarker.
Report Scope
The Prostate Cancer Biomarker market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Prostate Cancer Biomarker market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Prostate Cancer Biomarker companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Thermo Fisher Scientific
QIAGEN
Roche Diagnostics
Beckman Coulter
Myriad Genetics
Sanofi-Aventis
Pfizer
MDx Health
Segment by Type
Urine
Blood
Serum
Segment by Application
Hospitals
Clinics
Cancer Institutes
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Prostate Cancer Biomarker companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Prostate cancer is the development of cancer in the prostate, a gland in the male reproductive system.
The global Prostate Cancer Biomarker market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The prostate cancer biomarker market is expected to witness a fast growth owing to rising prevalence of prostate cancer.
This report aims to provide a comprehensive presentation of the global market for Prostate Cancer Biomarker, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Prostate Cancer Biomarker.
Report Scope
The Prostate Cancer Biomarker market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Prostate Cancer Biomarker market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Prostate Cancer Biomarker companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Thermo Fisher Scientific
QIAGEN
Roche Diagnostics
Beckman Coulter
Myriad Genetics
Sanofi-Aventis
Pfizer
MDx Health
Segment by Type
Urine
Blood
Serum
Segment by Application
Hospitals
Clinics
Cancer Institutes
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Prostate Cancer Biomarker companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Prostate Cancer Biomarker Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Urine
1.2.3 Blood
1.2.4 Serum
1.3 Market by Application
1.3.1 Global Prostate Cancer Biomarker Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Cancer Institutes
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Prostate Cancer Biomarker Market Perspective (2019-2030)
2.2 Prostate Cancer Biomarker Growth Trends by Region
2.2.1 Global Prostate Cancer Biomarker Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Prostate Cancer Biomarker Historic Market Size by Region (2019-2024)
2.2.3 Prostate Cancer Biomarker Forecasted Market Size by Region (2025-2030)
2.3 Prostate Cancer Biomarker Market Dynamics
2.3.1 Prostate Cancer Biomarker Industry Trends
2.3.2 Prostate Cancer Biomarker Market Drivers
2.3.3 Prostate Cancer Biomarker Market Challenges
2.3.4 Prostate Cancer Biomarker Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Prostate Cancer Biomarker Players by Revenue
3.1.1 Global Top Prostate Cancer Biomarker Players by Revenue (2019-2024)
3.1.2 Global Prostate Cancer Biomarker Revenue Market Share by Players (2019-2024)
3.2 Global Prostate Cancer Biomarker Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Prostate Cancer Biomarker Revenue
3.4 Global Prostate Cancer Biomarker Market Concentration Ratio
3.4.1 Global Prostate Cancer Biomarker Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Prostate Cancer Biomarker Revenue in 2023
3.5 Prostate Cancer Biomarker Key Players Head office and Area Served
3.6 Key Players Prostate Cancer Biomarker Product Solution and Service
3.7 Date of Enter into Prostate Cancer Biomarker Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Prostate Cancer Biomarker Breakdown Data by Type
4.1 Global Prostate Cancer Biomarker Historic Market Size by Type (2019-2024)
4.2 Global Prostate Cancer Biomarker Forecasted Market Size by Type (2025-2030)
5 Prostate Cancer Biomarker Breakdown Data by Application
5.1 Global Prostate Cancer Biomarker Historic Market Size by Application (2019-2024)
5.2 Global Prostate Cancer Biomarker Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Prostate Cancer Biomarker Market Size (2019-2030)
6.2 North America Prostate Cancer Biomarker Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Prostate Cancer Biomarker Market Size by Country (2019-2024)
6.4 North America Prostate Cancer Biomarker Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Prostate Cancer Biomarker Market Size (2019-2030)
7.2 Europe Prostate Cancer Biomarker Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Prostate Cancer Biomarker Market Size by Country (2019-2024)
7.4 Europe Prostate Cancer Biomarker Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Prostate Cancer Biomarker Market Size (2019-2030)
8.2 Asia-Pacific Prostate Cancer Biomarker Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Prostate Cancer Biomarker Market Size by Region (2019-2024)
8.4 Asia-Pacific Prostate Cancer Biomarker Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Prostate Cancer Biomarker Market Size (2019-2030)
9.2 Latin America Prostate Cancer Biomarker Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Prostate Cancer Biomarker Market Size by Country (2019-2024)
9.4 Latin America Prostate Cancer Biomarker Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Prostate Cancer Biomarker Market Size (2019-2030)
10.2 Middle East & Africa Prostate Cancer Biomarker Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Prostate Cancer Biomarker Market Size by Country (2019-2024)
10.4 Middle East & Africa Prostate Cancer Biomarker Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Thermo Fisher Scientific
11.1.1 Thermo Fisher Scientific Company Detail
11.1.2 Thermo Fisher Scientific Business Overview
11.1.3 Thermo Fisher Scientific Prostate Cancer Biomarker Introduction
11.1.4 Thermo Fisher Scientific Revenue in Prostate Cancer Biomarker Business (2019-2024)
11.1.5 Thermo Fisher Scientific Recent Development
11.2 QIAGEN
11.2.1 QIAGEN Company Detail
11.2.2 QIAGEN Business Overview
11.2.3 QIAGEN Prostate Cancer Biomarker Introduction
11.2.4 QIAGEN Revenue in Prostate Cancer Biomarker Business (2019-2024)
11.2.5 QIAGEN Recent Development
11.3 Roche Diagnostics
11.3.1 Roche Diagnostics Company Detail
11.3.2 Roche Diagnostics Business Overview
11.3.3 Roche Diagnostics Prostate Cancer Biomarker Introduction
11.3.4 Roche Diagnostics Revenue in Prostate Cancer Biomarker Business (2019-2024)
11.3.5 Roche Diagnostics Recent Development
11.4 Beckman Coulter
11.4.1 Beckman Coulter Company Detail
11.4.2 Beckman Coulter Business Overview
11.4.3 Beckman Coulter Prostate Cancer Biomarker Introduction
11.4.4 Beckman Coulter Revenue in Prostate Cancer Biomarker Business (2019-2024)
11.4.5 Beckman Coulter Recent Development
11.5 Myriad Genetics
11.5.1 Myriad Genetics Company Detail
11.5.2 Myriad Genetics Business Overview
11.5.3 Myriad Genetics Prostate Cancer Biomarker Introduction
11.5.4 Myriad Genetics Revenue in Prostate Cancer Biomarker Business (2019-2024)
11.5.5 Myriad Genetics Recent Development
11.6 Sanofi-Aventis
11.6.1 Sanofi-Aventis Company Detail
11.6.2 Sanofi-Aventis Business Overview
11.6.3 Sanofi-Aventis Prostate Cancer Biomarker Introduction
11.6.4 Sanofi-Aventis Revenue in Prostate Cancer Biomarker Business (2019-2024)
11.6.5 Sanofi-Aventis Recent Development
11.7 Pfizer
11.7.1 Pfizer Company Detail
11.7.2 Pfizer Business Overview
11.7.3 Pfizer Prostate Cancer Biomarker Introduction
11.7.4 Pfizer Revenue in Prostate Cancer Biomarker Business (2019-2024)
11.7.5 Pfizer Recent Development
11.8 MDx Health
11.8.1 MDx Health Company Detail
11.8.2 MDx Health Business Overview
11.8.3 MDx Health Prostate Cancer Biomarker Introduction
11.8.4 MDx Health Revenue in Prostate Cancer Biomarker Business (2019-2024)
11.8.5 MDx Health Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
